Published in Cancer Cell on October 18, 2011
Microenvironmental regulation of tumor progression and metastasis. Nat Med (2013) 8.37
Tumor-associated macrophages: from mechanisms to therapy. Immunity (2014) 4.69
VCAM-1 promotes osteolytic expansion of indolent bone micrometastasis of breast cancer by engaging α4β1-positive osteoclast progenitors. Cancer Cell (2011) 3.23
Tumor metastasis: moving new biological insights into the clinic. Nat Med (2013) 2.71
Silencing of Irf7 pathways in breast cancer cells promotes bone metastasis through immune escape. Nat Med (2012) 2.66
Origins of metastatic traits. Cancer Cell (2013) 2.49
Sensitizing protective tumor microenvironments to antibody-mediated therapy. Cell (2014) 2.43
Immune cell promotion of metastasis. Nat Rev Immunol (2015) 2.15
Targeting metastasis-initiating cells through the fatty acid receptor CD36. Nature (2016) 2.11
Tumor cell dissemination: emerging biological insights from animal models and cancer patients. Cancer Cell (2013) 2.08
CCL2-induced chemokine cascade promotes breast cancer metastasis by enhancing retention of metastasis-associated macrophages. J Exp Med (2015) 2.05
Metastatic stem cells: sources, niches, and vital pathways. Cell Stem Cell (2014) 1.88
Antibody therapy targeting the CD47 protein is effective in a model of aggressive metastatic leiomyosarcoma. Proc Natl Acad Sci U S A (2012) 1.86
Mechanisms governing metastatic dormancy and reactivation. Cell (2013) 1.81
P-selectin is a nanotherapeutic delivery target in the tumor microenvironment. Sci Transl Med (2016) 1.52
The metastasis-promoting roles of tumor-associated immune cells. J Mol Med (Berl) (2013) 1.40
The initial hours of metastasis: the importance of cooperative host-tumor cell interactions during hematogenous dissemination. Cancer Discov (2012) 1.40
Metastatic colonization by circulating tumour cells. Nature (2016) 1.31
The metastatic niche and stromal progression. Cancer Metastasis Rev (2012) 1.30
Targeting metastasis. Nat Rev Cancer (2016) 1.26
Platelets guide the formation of early metastatic niches. Proc Natl Acad Sci U S A (2014) 1.24
A role for CCL2 in both tumor progression and immunosurveillance. Oncoimmunology (2013) 1.15
Molecular pathways: VCAM-1 as a potential therapeutic target in metastasis. Clin Cancer Res (2012) 1.14
Extracellular matrix players in metastatic niches. EMBO J (2011) 1.13
Monocytes and macrophages in cancer: development and functions. Cancer Microenviron (2012) 1.06
Integrating new discoveries into the "vicious cycle" paradigm of prostate to bone metastases. Cancer Metastasis Rev (2014) 1.00
Caught in the act: revealing the metastatic process by live imaging. Dis Model Mech (2013) 0.99
Tumor-infiltrating myeloid cells activate Dll4/Notch/TGF-β signaling to drive malignant progression. Cancer Res (2014) 0.99
miR-155-deficient bone marrow promotes tumor metastasis. Mol Cancer Res (2013) 0.98
Angiotensin II facilitates breast cancer cell migration and metastasis. PLoS One (2012) 0.97
A role for PVRL4-driven cell-cell interactions in tumorigenesis. Elife (2013) 0.97
Human breast cancer cells educate macrophages toward the M2 activation status. Breast Cancer Res (2015) 0.97
Prostate cancer-derived CCN3 induces M2 macrophage infiltration and contributes to angiogenesis in prostate cancer microenvironment. Oncotarget (2014) 0.96
Ubiquitin-conjugating enzyme Ubc13 controls breast cancer metastasis through a TAK1-p38 MAP kinase cascade. Proc Natl Acad Sci U S A (2014) 0.96
Adhesion receptors as therapeutic targets for circulating tumor cells. Front Oncol (2012) 0.95
Emerging Biological Principles of Metastasis. Cell (2017) 0.94
Emerging roles of the tumor-associated stroma in promoting tumor metastasis. Cell Adh Migr (2012) 0.94
PI3Kα activates integrin α4β1 to establish a metastatic niche in lymph nodes. Proc Natl Acad Sci U S A (2013) 0.94
Epidermal growth factor (EGF)-enhanced vascular cell adhesion molecule-1 (VCAM-1) expression promotes macrophage and glioblastoma cell interaction and tumor cell invasion. J Biol Chem (2013) 0.93
The difference in prognostic factors between early recurrence and late recurrence in estrogen receptor-positive breast cancer: nodal stage differently impacts early and late recurrence. PLoS One (2013) 0.93
New Findings on Breast Cancer Stem Cells: A Review. J Breast Cancer (2015) 0.92
Tumor-associated macrophages: unwitting accomplices in breast cancer malignancy. NPJ Breast Cancer (2016) 0.92
Autoantibodies to Ezrin are an early sign of pancreatic cancer in humans and in genetically engineered mouse models. J Hematol Oncol (2013) 0.91
Distinctive properties of metastasis-initiating cells. Genes Dev (2016) 0.91
Emodin suppresses pulmonary metastasis of breast cancer accompanied with decreased macrophage recruitment and M2 polarization in the lungs. Breast Cancer Res Treat (2014) 0.91
Surviving at a distance: organ specific metastasis. Trends Cancer (2015) 0.90
Pivotal role of pervasive neoplastic and stromal cells reprogramming in circulating tumor cells dissemination and metastatic colonization. Cancer Microenviron (2014) 0.90
C-X-C motif chemokine 12/C-X-C chemokine receptor type 7 signaling regulates breast cancer growth and metastasis by modulating the tumor microenvironment. Breast Cancer Res (2014) 0.90
Immunomodulation via Chemotherapy and Targeted Therapy: A New Paradigm in Breast Cancer Therapy? Breast Care (Basel) (2012) 0.90
Contact-dependent carcinoma aggregate dispersion by M2a macrophages via ICAM-1 and β2 integrin interactions. Oncotarget (2015) 0.88
Genetics of breast cancer bone metastasis: a sequential multistep pattern. Clin Exp Metastasis (2014) 0.87
Ezrin regulates focal adhesion and invadopodia dynamics by altering calpain activity to promote breast cancer cell invasion. Mol Biol Cell (2015) 0.87
Bone metastasis: the importance of the neighbourhood. Nat Rev Cancer (2016) 0.86
FLT1 signaling in metastasis-associated macrophages activates an inflammatory signature that promotes breast cancer metastasis. J Exp Med (2015) 0.86
Identification of novel metastasis suppressor signaling pathways for breast cancer. Cell Cycle (2012) 0.86
CSF1-ETS2-induced microRNA in myeloid cells promote metastatic tumor growth. Oncogene (2014) 0.86
Hormonally responsive breast cancer cells in a microfluidic co-culture model as a sensor of microenvironmental activity. Integr Biol (Camb) (2013) 0.85
Harnessing the immune system for the treatment of breast cancer. J Zhejiang Univ Sci B (2014) 0.85
Targeting Breast Cancer Metastasis. Breast Cancer (Auckl) (2015) 0.85
Immune approaches to the treatment of breast cancer, around the corner? Breast Cancer Res (2014) 0.85
Concise review: breast cancer stem cells: regulatory networks, stem cell niches, and disease relevance. Stem Cells Transl Med (2014) 0.83
PET Imaging of Tumor-Associated Macrophages with 89Zr-Labeled High-Density Lipoprotein Nanoparticles. J Nucl Med (2015) 0.83
The Tumor Macroenvironment: Cancer-Promoting Networks Beyond Tumor Beds. Adv Cancer Res (2015) 0.83
Tumour cells coerce host tissue to cancer spread. Bonekey Rep (2013) 0.82
Lipopolysaccharide modulates neutrophil recruitment and macrophage polarization on lymphatic vessels and impairs lymphatic function in rat mesentery. Am J Physiol Heart Circ Physiol (2015) 0.81
New tricks for metastasis-associated macrophages. Breast Cancer Res (2012) 0.81
WNT5A signaling impairs breast cancer cell migration and invasion via mechanisms independent of the epithelial-mesenchymal transition. J Exp Clin Cancer Res (2016) 0.80
New and emerging factors in tumorigenesis: an overview. Cancer Manag Res (2015) 0.80
The emerging molecular machinery and therapeutic targets of metastasis. Trends Pharmacol Sci (2015) 0.80
Sensitive and Specific Biomimetic Lipid Coated Microfluidics to Isolate Viable Circulating Tumor Cells and Microemboli for Cancer Detection. PLoS One (2016) 0.80
Inflammation and skeletal metastasis. Bonekey Rep (2015) 0.79
Therapeutic potential of chemokine signal inhibition for metastatic breast cancer. Pharmacol Res (2015) 0.78
Lung-derived factors mediate breast cancer cell migration through CD44 receptor-ligand interactions in a novel ex vivo system for analysis of organ-specific soluble proteins. Neoplasia (2014) 0.78
Metastatic Competence Can Emerge with Selection of Preexisting Oncogenic Alleles without a Need of New Mutations. Cancer Res (2015) 0.78
Tumor microenvironment: driving forces and potential therapeutic targets for breast cancer metastasis. Chin J Cancer (2017) 0.78
Tumor-associated macrophages drive spheroid formation during early transcoelomic metastasis of ovarian cancer. J Clin Invest (2016) 0.78
Battle over CCL2 for control of the metastatic niche: neutrophils versus monocytes. Breast Cancer Res (2012) 0.77
Screening candidate metastasis-associated genes in three-dimensional HCC spheroids with different metastasis potential. Int J Clin Exp Pathol (2014) 0.77
A pH-Responsive Host-guest Nanosystem Loading Succinobucol Suppresses Lung Metastasis of Breast Cancer. Theranostics (2016) 0.76
Microfluidics: A new tool for modeling cancer-immune interactions. Trends Cancer (2016) 0.76
Metastasis of circulating tumor cells: Favorable soil or suitable biomechanics, or both? Cell Adh Migr (2015) 0.76
Fibrotic microenvironment promotes the metastatic seeding of tumor cells via activating the fibronectin 1/secreted phosphoprotein 1-integrin signaling. Oncotarget (2016) 0.76
Methods for analysis of the cancer microenvironment and their potential for disease prediction, monitoring and personalized treatments. EPMA J (2012) 0.76
Metastatic cells will take any help they can get. Cancer Cell (2011) 0.75
Targeting signal transduction pathways of cancer stem cells for therapeutic opportunities of metastasis. Oncotarget (2016) 0.75
Immune Regulation of the Metastatic Process: Implications for Therapy. Adv Cancer Res (2016) 0.75
The Contribution of Cholesterol and Its Metabolites to the Pathophysiology of Breast Cancer. Horm Cancer (2016) 0.75
Tumor-recruited M2 macrophages promote gastric and breast cancer metastasis via M2 macrophage-secreted CHI3L1 protein. J Hematol Oncol (2017) 0.75
Means to the ends: The role of telomeres and telomere processing machinery in metastasis. Biochim Biophys Acta (2016) 0.75
VHL promotes immune response against renal cell carcinoma via NF-κB-dependent regulation of VCAM-1. J Cell Biol (2017) 0.75
Adaptive Stress Responses During Tumor Metastasis and Dormancy. Trends Cancer (2016) 0.75
One microenvironment does not fit all: heterogeneity beyond cancer cells. Cancer Metastasis Rev (2016) 0.75
Phase I study on the safety, pharmacokinetic profile, and efficacy of the combination of TSU-68, an oral antiangiogenic agent, and S-1 in patients with advanced hepatocellular carcinoma. Invest New Drugs (2014) 0.75
Targeting tumor-associated macrophages to combat pancreatic cancer. Oncotarget (2016) 0.75
New Mechanisms of Tumor-Associated Macrophages on Promoting Tumor Progression: Recent Research Advances and Potential Targets for Tumor Immunotherapy. J Immunol Res (2016) 0.75
Macrophages as Key Drivers of Cancer Progression and Metastasis. Mediators Inflamm (2017) 0.75
Metastatic site-specific polarization of macrophages in intracranial breast cancer metastases. Oncotarget (2016) 0.75
The Relationship Between Dormant Cancer Cells and Their Microenvironment. Adv Cancer Res (2016) 0.75
CXCR3(+) monocytes/macrophages are required for establishment of pulmonary metastases. Sci Rep (2017) 0.75
RNA Sequencing Analysis Reveals Interactions between Breast Cancer or Melanoma Cells and the Tissue Microenvironment during Brain Metastasis. Biomed Res Int (2017) 0.75
Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science (2005) 38.99
Involvement of chemokine receptors in breast cancer metastasis. Nature (2001) 26.07
The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nat Rev Cancer (2003) 22.78
mTOR: from growth signal integration to cancer, diabetes and ageing. Nat Rev Mol Cell Biol (2010) 21.16
Genes that mediate breast cancer metastasis to lung. Nature (2005) 19.85
A multigenic program mediating breast cancer metastasis to bone. Cancer Cell (2003) 16.86
Mechanism of activation of protein kinase B by insulin and IGF-1. EMBO J (1996) 16.68
Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis. Cancer Cell (2009) 16.06
Microenvironmental regulation of metastasis. Nat Rev Cancer (2008) 15.76
VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature (2005) 15.57
Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature (1995) 15.07
Endogenous human microRNAs that suppress breast cancer metastasis. Nature (2008) 14.37
Metastasis: from dissemination to organ-specific colonization. Nat Rev Cancer (2009) 14.17
Macrophage diversity enhances tumor progression and metastasis. Cell (2010) 13.41
Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer. Breast Cancer Res (2010) 10.90
Molecular characterization of the tumor microenvironment in breast cancer. Cancer Cell (2004) 9.41
Direct expression cloning of vascular cell adhesion molecule 1, a cytokine-induced endothelial protein that binds to lymphocytes. Cell (1989) 9.06
Selective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse mammary tumor. Cancer Res (1992) 9.02
VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from the VLA-4/fibronectin binding site. Cell (1990) 8.87
CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis. Nature (2011) 8.62
Genes that mediate breast cancer metastasis to the brain. Nature (2009) 8.23
TGFbeta primes breast tumors for lung metastasis seeding through angiopoietin-like 4. Cell (2008) 7.60
A paracrine loop between tumor cells and macrophages is required for tumor cell migration in mammary tumors. Cancer Res (2004) 7.56
Mediators of vascular remodelling co-opted for sequential steps in lung metastasis. Nature (2007) 7.05
Tumor self-seeding by circulating cancer cells. Cell (2009) 6.66
Macrophages regulate the angiogenic switch in a mouse model of breast cancer. Cancer Res (2006) 6.52
Breast tumor cell lines from pleural effusions. J Natl Cancer Inst (1974) 5.39
TGF-beta signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases development. J Clin Invest (1999) 5.30
Regulation of cancer cell migration and bone metastasis by RANKL. Nature (2006) 5.27
Latent bone metastasis in breast cancer tied to Src-dependent survival signals. Cancer Cell (2009) 5.24
Organizing the cell cortex: the role of ERM proteins. Nat Rev Mol Cell Biol (2010) 5.05
Endothelial progenitor cells control the angiogenic switch in mouse lung metastasis. Science (2008) 4.71
Multistep nature of metastatic inefficiency: dormancy of solitary cells after successful extravasation and limited survival of early micrometastases. Am J Pathol (1998) 4.41
An amino-bisphosphonate targets MMP-9-expressing macrophages and angiogenesis to impair cervical carcinogenesis. J Clin Invest (2004) 4.03
Lung metastasis genes couple breast tumor size and metastatic spread. Proc Natl Acad Sci U S A (2007) 3.92
A distinct macrophage population mediates metastatic breast cancer cell extravasation, establishment and growth. PLoS One (2009) 3.86
IL-4 induces cathepsin protease activity in tumor-associated macrophages to promote cancer growth and invasion. Genes Dev (2010) 3.56
Dynamic interaction of VCAM-1 and ICAM-1 with moesin and ezrin in a novel endothelial docking structure for adherent leukocytes. J Cell Biol (2002) 3.16
In vivo role of the PIF-binding docking site of PDK1 defined by knock-in mutation. EMBO J (2003) 2.74
Temporal progression of metastasis in lung: cell survival, dormancy, and location dependence of metastatic inefficiency. Cancer Res (2000) 2.58
VCAM-1-mediated Rac signaling controls endothelial cell-cell contacts and leukocyte transmigration. Am J Physiol Cell Physiol (2003) 2.37
Ezrin, a plasma membrane-microfilament linker, signals cell survival through the phosphatidylinositol 3-kinase/Akt pathway. Proc Natl Acad Sci U S A (1999) 2.21
Identification of the two major epidermal growth factor-induced tyrosine phosphorylation sites in the microvillar core protein ezrin. J Biol Chem (1992) 1.86
Gene structure, chromosomal location, and basis for alternative mRNA splicing of the human VCAM1 gene. Proc Natl Acad Sci U S A (1991) 1.79
Cancer spread and micrometastasis development: quantitative approaches for in vivo models. Bioessays (2002) 1.76
Apoptosis: an early event in metastatic inefficiency. Cancer Res (2001) 1.74
Macrophage-derived SPARC bridges tumor cell-extracellular matrix interactions toward metastasis. Cancer Res (2008) 1.61
Specific cross-talk between epidermal growth factor receptor and integrin alphavbeta5 promotes carcinoma cell invasion and metastasis. Cancer Res (2009) 1.44
Residues within a conserved amino acid motif of domains 1 and 4 of VCAM-1 are required for binding to VLA-4. J Cell Biol (1994) 1.43
Association of VCAM-1 overexpression with oncogenesis, tumor angiogenesis and metastasis of gastric carcinoma. World J Gastroenterol (2003) 1.33
Activation of the PKB/AKT pathway by ICAM-2. Immunity (2002) 1.31
Human macrophages promote the motility and invasiveness of osteopontin-knockdown tumor cells. Cancer Res (2007) 1.25
Androgen induction of prostate cancer cell invasion is mediated by ezrin. J Biol Chem (2006) 1.12
Differential monocyte adhesion and adhesion molecule expression in venous and arterial endothelial cells. Am J Physiol (1999) 0.98
The regulation of pulmonary immunity. Adv Immunol (1995) 0.98
Caveolin-1 is associated with VCAM-1 dependent adhesion of gastric cancer cells to endothelial cells. Cell Physiol Biochem (2006) 0.96
Disparities in the survival improvement of recurrent breast cancer. Breast Cancer (2009) 0.90
Role of catalase in monocytic differentiation of U937 cells by TPA: hydrogen peroxide as a second messenger. Leukemia (2008) 0.89
Treatment of multiple sclerosis: role of natalizumab. Neurol Sci (2009) 0.88
Expression of ICAM-1 and VCAM-1 in human malignant mesothelioma. J Pathol (1996) 0.87
Regulation of complement 5a receptor expression in U937 cells by phorbol ester. J Leukoc Biol (1991) 0.84
Crohn's targeted therapy: myth or real goal? Curr Drug Discov Technol (2009) 0.82
Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell (2003) 25.94
Genes that mediate breast cancer metastasis to lung. Nature (2005) 19.85
Cancer metastasis: building a framework. Cell (2006) 19.67
A multigenic program mediating breast cancer metastasis to bone. Cancer Cell (2003) 16.86
Endogenous human microRNAs that suppress breast cancer metastasis. Nature (2008) 14.37
Metastasis: from dissemination to organ-specific colonization. Nat Rev Cancer (2009) 14.17
Cytostatic and apoptotic actions of TGF-beta in homeostasis and cancer. Nat Rev Cancer (2003) 8.35
Genes that mediate breast cancer metastasis to the brain. Nature (2009) 8.23
Molecular basis of metastasis. N Engl J Med (2008) 8.19
TGFbeta primes breast tumors for lung metastasis seeding through angiopoietin-like 4. Cell (2008) 7.60
Genome-wide RNAi screen of Ca(2+) influx identifies genes that regulate Ca(2+) release-activated Ca(2+) channel activity. Proc Natl Acad Sci U S A (2006) 7.26
Epithelial-mesenchymal transitions: twist in development and metastasis. Cell (2004) 7.14
Mediators of vascular remodelling co-opted for sequential steps in lung metastasis. Nature (2007) 7.05
Tumor self-seeding by circulating cancer cells. Cell (2009) 6.66
Genetic determinants of cancer metastasis. Nat Rev Genet (2007) 6.38
Integration of Smad and forkhead pathways in the control of neuroepithelial and glioblastoma cell proliferation. Cell (2004) 6.35
Distinct organ-specific metastatic potential of individual breast cancer cells and primary tumors. J Clin Invest (2005) 6.10
Myc suppression of the p21(Cip1) Cdk inhibitor influences the outcome of the p53 response to DNA damage. Nature (2002) 5.25
Latent bone metastasis in breast cancer tied to Src-dependent survival signals. Cancer Cell (2009) 5.24
A CXCL1 paracrine network links cancer chemoresistance and metastasis. Cell (2012) 4.89
Nuclear CDKs drive Smad transcriptional activation and turnover in BMP and TGF-beta pathways. Cell (2009) 4.81
TGF-beta directly targets cytotoxic T cell functions during tumor evasion of immune surveillance. Cancer Cell (2005) 4.46
Roles of TGFbeta in metastasis. Cell Res (2009) 4.35
Breast cancer cells produce tenascin C as a metastatic niche component to colonize the lungs. Nat Med (2011) 4.25
Breast cancer bone metastasis mediated by the Smad tumor suppressor pathway. Proc Natl Acad Sci U S A (2005) 4.20
Lung metastasis genes couple breast tumor size and metastatic spread. Proc Natl Acad Sci U S A (2007) 3.92
E2F4/5 and p107 as Smad cofactors linking the TGFbeta receptor to c-myc repression. Cell (2002) 3.87
WNT/TCF signaling through LEF1 and HOXB9 mediates lung adenocarcinoma metastasis. Cell (2009) 3.76
Beyond tumorigenesis: cancer stem cells in metastasis. Cell Res (2007) 3.63
Transforming growth factor beta signaling impairs Neu-induced mammary tumorigenesis while promoting pulmonary metastasis. Proc Natl Acad Sci U S A (2003) 3.61
A self-enabling TGFbeta response coupled to stress signaling: Smad engages stress response factor ATF3 for Id1 repression in epithelial cells. Mol Cell (2003) 3.57
Selection of bone metastasis seeds by mesenchymal signals in the primary tumor stroma. Cell (2013) 3.33
Hematopoiesis controlled by distinct TIF1gamma and Smad4 branches of the TGFbeta pathway. Cell (2006) 3.31
VCAM-1 promotes osteolytic expansion of indolent bone micrometastasis of breast cancer by engaging α4β1-positive osteoclast progenitors. Cancer Cell (2011) 3.23
Balancing BMP signaling through integrated inputs into the Smad1 linker. Mol Cell (2007) 3.23
Is cancer a disease of self-seeding? Nat Med (2006) 3.19
Epigenetic expansion of VHL-HIF signal output drives multiorgan metastasis in renal cancer. Nat Med (2012) 2.95
Dependency of colorectal cancer on a TGF-β-driven program in stromal cells for metastasis initiation. Cancer Cell (2012) 2.94
C/EBPbeta at the core of the TGFbeta cytostatic response and its evasion in metastatic breast cancer cells. Cancer Cell (2006) 2.87
ID genes mediate tumor reinitiation during breast cancer lung metastasis. Proc Natl Acad Sci U S A (2007) 2.85
A FoxO-Smad synexpression group in human keratinocytes. Proc Natl Acad Sci U S A (2006) 2.60
ADAMTS1 and MMP1 proteolytically engage EGF-like ligands in an osteolytic signaling cascade for bone metastasis. Genes Dev (2009) 2.59
Origins of metastatic traits. Cancer Cell (2013) 2.49
Ubiquitin ligase Nedd4L targets activated Smad2/3 to limit TGF-beta signaling. Mol Cell (2009) 2.45
Sorting out breast-cancer gene signatures. N Engl J Med (2007) 2.22
Smad2 nucleocytoplasmic shuttling by nucleoporins CAN/Nup214 and Nup153 feeds TGFbeta signaling complexes in the cytoplasm and nucleus. Mol Cell (2002) 2.05
Nucleocytoplasmic shuttling of signal transducers. Nat Rev Mol Cell Biol (2004) 2.04
Direct binding of Smad1 and Smad4 to two distinct motifs mediates bone morphogenetic protein-specific transcriptional activation of Id1 gene. J Biol Chem (2001) 1.99
Dynamic regulation of alternative splicing by silencers that modulate 5' splice site competition. Cell (2008) 1.91
MicroRNA-335 inhibits tumor reinitiation and is silenced through genetic and epigenetic mechanisms in human breast cancer. Genes Dev (2011) 1.85
A poised chromatin platform for TGF-β access to master regulators. Cell (2011) 1.81
Structural basis for the versatile interactions of Smad7 with regulator WW domains in TGF-β Pathways. Structure (2012) 1.77
Clinical implications of cancer self-seeding. Nat Rev Clin Oncol (2011) 1.77
Transforming growth factor beta-induced cell cycle arrest of human hematopoietic cells requires p57KIP2 up-regulation. Proc Natl Acad Sci U S A (2004) 1.71
Dephosphorylation of the linker regions of Smad1 and Smad2/3 by small C-terminal domain phosphatases has distinct outcomes for bone morphogenetic protein and transforming growth factor-beta pathways. J Biol Chem (2006) 1.63
A Smad action turnover switch operated by WW domain readers of a phosphoserine code. Genes Dev (2011) 1.60
Unique players in the BMP pathway: small C-terminal domain phosphatases dephosphorylate Smad1 to attenuate BMP signaling. Proc Natl Acad Sci U S A (2006) 1.52
Modeling metastasis in the mouse. Curr Opin Pharmacol (2010) 1.46
Genome-wide impact of the BRG1 SWI/SNF chromatin remodeler on the transforming growth factor beta transcriptional program. J Biol Chem (2007) 1.43
Distinct domain utilization by Smad3 and Smad4 for nucleoporin interaction and nuclear import. J Biol Chem (2003) 1.31
Breast cancer banishes p27 from nucleus. Nat Med (2002) 1.25
Diverted total synthesis leads to the generation of promising cell-migration inhibitors for treatment of tumor metastasis: in vivo and mechanistic studies on the migrastatin core ether analog. J Am Chem Soc (2010) 1.19
Positive selection acting on splicing motifs reflects compensatory evolution. Genome Res (2008) 1.18
Molecular pathways: VCAM-1 as a potential therapeutic target in metastasis. Clin Cancer Res (2012) 1.14
Extracellular matrix players in metastatic niches. EMBO J (2011) 1.13
Mad upregulation and Id2 repression accompany transforming growth factor (TGF)-beta-mediated epithelial cell growth suppression. J Biol Chem (2003) 1.11
Features of a Smad3 MH1-DNA complex. Roles of water and zinc in DNA binding. J Biol Chem (2003) 1.11
Platelets and metastasis revisited: a novel fatty link. J Clin Invest (2004) 1.07
HER2 silences tumor suppression in breast cancer cells by switching expression of C/EBPß isoforms. Cancer Res (2010) 1.00
Signalling change: signal transduction through the decades. Nat Rev Mol Cell Biol (2013) 0.99
Opposite Smad and chicken ovalbumin upstream promoter transcription factor inputs in the regulation of the collagen VII gene promoter by transforming growth factor-beta. J Biol Chem (2004) 0.99
Cyclin-dependent kinase inhibitors uncouple cell cycle progression from mitochondrial apoptotic functions in DNA-damaged cancer cells. J Biol Chem (2005) 0.96
Breast cancer tumor size, nodal status, and prognosis: biology trumps anatomy. J Clin Oncol (2011) 0.95
Ubiquitin removal in the TGF-β pathway. Nat Cell Biol (2012) 0.89
BMP/Coco antagonism as a deterministic factor of metastasis dormancy in lung. Breast Cancer Res (2013) 0.80
Field cancerization: something new under the sun. Cell (2012) 0.80
Hypoxia signaling--license to metastasize. Cancer Discov (2013) 0.78
Retrieval of Disseminated Tumor Cells Colonizing the Bone in Murine Breast Cancer Metastasis Models. J Mammary Gland Biol Neoplasia (2015) 0.76
Cell regulation. Curr Opin Cell Biol (2008) 0.76
Corrigendum: Carcinoma-astrocyte gap junctions promote brain metastasis by cGAMP transfer. Nature (2017) 0.75
Erratum: Oncogenic mTOR signalling recruits myeloid-derived suppressor cells to promote tumour initiation. Nat Cell Biol (2016) 0.75
[Receptors and functions of TGF-beta, a crucial cytokine in wound healing]. Gac Med Mex (2003) 0.75
Molecules in the blood of older people promote cancer spread. Nature (2020) 0.75